Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website


  • We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

    To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.  

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  160942 of 162059  at  10/27/2021 12:56:40 PM  by

bct1192


Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

 
Technically old news, but new article.
 
Sort of hard to reconcile the dichotomy of SGMO at $8.10 against the backdrop of SGMO performed pre clinical work that helps to validate this white hot burgeoning space in CAR-TRegs for autoimmune diseases that is seeing new companies enter the space seemingly daily, some with private seed money that likely gives them valuations on par with SGMO presently when they have nothing else going on.
 
It either speaks to the tremendous value that SGMO is, or the tremendous value trap that SGMO is...
 
It's almost as if it has already been assumed that even though SGMO was first here too, it will ultimately get leapfrogged yet again.
 
I have harped incessantly on execution, and with respect to CAR-TRegs, it is paramount here more than ever.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 19  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
160943 Re: Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease JamieSoftware 13 10/27/2021 2:02:47 PM


Financial Market Data provided by
.
Loading...